Cingulate (CINGW) Interest & Investment Income (2025 - 2026)
Cingulate's (CINGW) quarterly Interest & Investment Income came in at -$141276.0 in Q2 2026, down 1.81% on a YoY basis from -$143883.9 in Q2 2025, and down 1.81% quarter-over-quarter from -$138761.0 in Q2 2025.
Powered by 
Analysis
Cingulate (CINGW) Interest & Investment Income (2025 - 2026) Analysis & Trends
Cingulate (CINGW) has reported Interest & Investment Income for 2 consecutive years, with -$141276.0 the latest figure, recorded in Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 644.32 Bn | 623.56 Bn | 17.26 Bn | 219.00 Mn |
| 2 | AbbVie | 440.60 Bn | 434.04 Bn | 12.70 Bn | -679.00 Mn |
| 3 | Merck | 365.39 Bn | 358.25 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | - |
| 5 | Pfizer | 159.22 Bn | 147.52 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.48 Bn | 45.10 Bn | 10.79 Bn | 89.50 Mn |
| 7 | Revolution Medicines | 44.21 Bn | 44.21 Bn | - | 35.58 Mn |
| 8 | Incyte | 25.34 Bn | 20.81 Bn | 1.57 Bn | 38.12 Mn |
| 9 | United Therapeutics | 21.49 Bn | 18.82 Bn | 683.80 Mn | 31.50 Mn |
| 10 | Cingulate | 100,214.03 | 100,214.03 | - | -141,276.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -141,276.00 |
| Jun 30, 2025 | -138,761.00 |